ARCA biopharma (ABIO) said late Friday that it will distribute a special dividend estimated to be $1.59 per share, subject to approval of the proposed merger with Oruka Therapeutics by ARCA shareholders.
The exact amount of the dividend will be based on the merger agreement and ARCA's estimate of how much its net cash exceeds $5 million before the merger closes, the company said.
The dividend is payable on Aug. 28 to shareholders of record on Aug. 26, the company said.
The proposed merger is expected to close on Aug. 29.
Shares of ARCA were up about 13% in recent after-hours activity.
Price: 3.3200, Change: +0.37, Percent Change: +12.54
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。